Table 5.
Distribution of operative ratios and 90-day hemoptysis-related mortality rates for different cohorts
| Definitive diagnosis | Total number of patients | Operated patients | Non-operated patients | ||
|---|---|---|---|---|---|
| n (%) | Mortality (%) | n (%) | Mortality (%) | ||
| Primary lung malignancy | 40 | 4 (10) | 1 (25) | 36 (90) | 19 (53) |
| Tuberculosis | 42 | 8 (19) | 1 (13) | 34 (81) | 3 (9) |
| Bronchiectasis | 31 | 13 (42) | 0 (0) | 18 (58) | 2 (11) |
| Aspergilloma | 6 | 4 (67) | 0 (0) | 2 (33) | 0 (0) |
| Others* | 39 | 2 (5) | 0 (0) | 37 (95) | 9 (24) |
| No definitive diagnosis | 45 | 0 (0) | 0 (0) | 45 (100) | 4 (9) |
*Others: Arteriovenous malformation, Behçet’s disease, congestive heart failure, excessive anticoagulation,hydatic cyst, hypertention, lung abcess, pneumonia, secondary lung malignancies